The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
Field | Value | Language |
dc.contributor.author | Koirala, Archana | en_AU |
dc.contributor.author | Gidding, Heather F | en_AU |
dc.contributor.author | Vette, Kaitlyn | en_AU |
dc.contributor.author | Macartney, Kristine | en_AU |
dc.contributor.author | Wood, Nicholas | en_AU |
dc.contributor.author | Britton, Philip N | en_AU |
dc.contributor.author | Wurzel, Danielle | en_AU |
dc.contributor.author | Marshall, Helen | en_AU |
dc.contributor.author | Clark, Julia E | en_AU |
dc.contributor.author | Wadia, Ushma | en_AU |
dc.contributor.author | Crawford, Nigel W | en_AU |
dc.contributor.author | Richmond, Peter | en_AU |
dc.contributor.author | Bartlett, Adam | en_AU |
dc.contributor.author | Carr, Jeremy | en_AU |
dc.contributor.author | O’Sullivan, Matthew VN | en_AU |
dc.contributor.author | Nicholson, Suellen | en_AU |
dc.contributor.author | Downes, Marnie | en_AU |
dc.contributor.author | Carlin, John | en_AU |
dc.contributor.author | Skowno, Justin | en_AU |
dc.contributor.author | Hannah, Donald | en_AU |
dc.contributor.author | Davidson, Andrew | en_AU |
dc.contributor.author | Ungern‐Sternberg, Britta | en_AU |
dc.contributor.author | Burgoyne, Laura | en_AU |
dc.contributor.author | Archer, Paul‐Lee | en_AU |
dc.date.accessioned | 2022-07-04T00:45:44Z | |
dc.date.available | 2022-07-04T00:45:44Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://hdl.handle.net/2123/28996 | |
dc.language.iso | en | en_AU |
dc.subject | COVID-19 | en_AUI |
dc.subject | Coronavirus | en_AUI |
dc.title | The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021 | en_AU |
dc.type | Article | en_AU |
dc.identifier.doi | 10.5694/mja2.51542 |
Associated file/s
There are no files associated with this item.
Associated collections